EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Post-COVID Myocarditis in Patients with Primary Cardiomyopathies: Diagnosis, Clinical Course and Outcomes

Olga Blagova iD, Yulia Lutokhina iD, Evgeniya Kogan, Polina Savina iD, Svetlana Aleksandrova, Elena Zaklyazminskaya iD

Genes · 2024

DOI: 10.3390/genes15081062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Olga Blagova und 5 weiteren Autor:innen. Beteiligte Einrichtung: V.N. Vinogradov Faculty Therapeutic Clinic, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia. Hauptthemen laut MEDLINE: COVID-19, Myocarditis, SARS-CoV-2, Cardiomyopathies. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Academy of Science, Sechenov University, Russian Academy of Science Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to evaluate the clinical course and outcomes of post-COVID myocarditis in patients with cardiomyopathies (CMP). This case series includes 10 patients with different CMPs who had COVID-19 (seven men; 48.4 ± 11.4 yr.): left ventricular non-compaction (n = 2), arrhythmogenic right ventricular CMP in combination with a heterozygous form of hemochromatosis (n = 1, HFE), restrictive CMP (n = 1, MyBPC3), laminopathy (n = 1, LMNA), dilated cardiomyopathy (n = 1, MYH7 + MyBPC3), Danon’s disease (n = 1, LAMP2) and AL cardiac amyloidosis (n = 3). Myocardial morphological examination with immunohistochemical staining and PCR for SARS-CoV-2 and cardiotropic viruses was performed in six patients, while cardiac MRI and anti-cardiac antibody titres were evaluated in all patients. Post-COVID lymphocytic myocarditis was confirmed morphologically in six patients (with LVNC, RCM, ARCV, Danon’s disease, and AL amyloidosis). Spike and nucleocapsid coronavirus proteins were detected in cell infiltrates, endothelium and cardiomyocytes in all biopsies; SARS-CoV-2 RNA was found in five out of six. In four patients, the diagnosis of myocarditis was based on MRI, high titres of anti-cardiac antibodies and clinical data. The mean time from COVID-19 to the diagnosis of myocarditis was 7 (5; 10.5) months. Myocarditis manifested with the onset/increase of arrhythmias and heart failure. Immunosuppressive therapy with corticosteroids was administered to six patients and led to an increase in ejection fraction and improvement of heart failure symptoms in five of them. CMPs are a favourable background for the development of post-COVID myocarditis. The onset or deterioration of heart failure and/or arrhythmias in patients with CMPs after COVID-19 requires the exclusion of myocarditis and, if present, the administration of immunosuppressive therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MyocarditisSARS-CoV-2CardiomyopathiesHumansMaleFemaleMiddle AgedAdultMyocardium

Stichwörter der Autor:innen

COVID-19SARS-CoV-2arrhythmiacardiomyopathyendomyocardial biopsyheart failureinflammationmyocarditis

Autor:innen und Institutionen

  • V.N. Vinogradov Faculty Therapeutic Clinic, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
  • Department of Pathology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
  • Department of Radiology, A. N. Bakulev National Medical Research Center for Cardiovascular Surgery of the Russian Ministry of Health, 121552 Moscow, Russia.
  • Laboratory of Medical Genetics, B.V. Petrovsky Russian Research Center of Surgery, 119991 Moscow, Russia.

ORCID-Profile: Olga Blagova, Yulia Lutokhina, Polina Savina, Elena Zaklyazminskaya

Förderung

  • Russian Academy of Science
  • Sechenov University
  • Russian Academy of Science Project
  • Sechenov University Innovative Scientific School

Zitieren

APA

Blagova, O., Lutokhina, Y., Kogan, E., Savina, P., Aleksandrova, S., & Zaklyazminskaya, E. (2024). Post-COVID Myocarditis in Patients with Primary Cardiomyopathies: Diagnosis, Clinical Course and Outcomes. Genes. https://doi.org/10.3390/genes15081062

Vancouver

Blagova O, Lutokhina Y, Kogan E, Savina P, Aleksandrova S, Zaklyazminskaya E. Post-COVID Myocarditis in Patients with Primary Cardiomyopathies: Diagnosis, Clinical Course and Outcomes. Genes. 2024. doi:10.3390/genes15081062

BibTeX
@article{Blagova2024,
  author = {Blagova, Olga and Lutokhina, Yulia and Kogan, Evgeniya and Savina, Polina and Aleksandrova, Svetlana and Zaklyazminskaya, Elena},
  title = {Post-COVID Myocarditis in Patients with Primary Cardiomyopathies: Diagnosis, Clinical Course and Outcomes},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15081062}
}
Kostenlos starten →